George Sfikas

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

Antonio J. Vallejo‐Vaz, Christophe Stevens, Alexander R.M. Lyons et al. · The Lancet · 2021 · 305 citations · Full text

Public Health, Endocrinology, Genetics +13

Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study

Kanika Dharmayat, Antonio J. Vallejo‐Vaz, Christophe Stevens et al. · The Lancet · 2023 · 79 citations · Full text

Public Health, Child Health, Pediatrics +14

Incidence of pulmonary hypertension in patients with chronic myeloproliferative disorders.

Vasilia Garypidou, Sofia Vakalopoulou, Dimokritos Dimitriadis et al. · PubMed · 2004 · 61 citations

Medicine, Hematology, Pulmonology +7

LDL cholesterol target achievement in heterozygous familial hypercholesterolemia patients according to 2019 ESC/EAS lipid guidelines: Implications for newer lipid-lowering treatments

Christos V. Rizos, Ioannis Skoumas, Lοukianos S. Rallidis et al. · International Journal of Cardiology · 2021 · 27 citations

Medicine, Cardiology, Endocrinology +16

Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study

Amany Elshorbagy, Alexander R.M. Lyons, Antonio J. Vallejo‐Vaz et al. · The Lancet Diabetes & Endocrinology · 2024 · 13 citations · Full text

Medicine, Endocrinology, Internal Medicine +11